Literature DB >> 12670496

In vitro assessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by human CYP1A1.

Dieter Schwarz1, Ivar Roots.   

Abstract

Previously, inhibitors of CYP1A1 were rated as candidate chemopreventive agents against cancer mainly according to their effects on the 7-ethoxyresorufin O-deethylation (EROD) of diagnostic probe substrates. Surprisingly, several polyphenols including resveratrol, formerly identified as potent inhibitors by the EROD assay, exhibited no or weak inhibition of procarcinogen activation. We compared the effects of 11 representative natural polyphenols, which normally occur in food, on different activities of CYP1A1, namely epoxidation of 7,8-dihydrodiol-benzo[a]pyrene, the terminal step in the activation leading to the ultimate carcinogenic diolepoxides, hydroxylation of benzo[a]pyrene, and EROD. For the first time, a reconstituted system was used for the determination of IC(50) values, consisting of purified enzymes (human CYP1A1 and human NADPH-cytochrome P450 reductase) and dilaurylphosphatidylcholine. The results demonstrate that the inhibitory effects of dietary polyphenols on CYP1A1 activity depend on both the structure of the inhibitor and the type of the reaction and substrate used in the assay. Consequently, a potent EROD inhibition alone is insufficient to count a substance among the chemoprotective agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670496     DOI: 10.1016/s0006-291x(03)00435-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

2.  Effects of acetylenic epoxygenase inhibitors on recombinant cytochrome p450s.

Authors:  Melissa A VanAlstine; Lindsay B Hough
Journal:  Drug Metab Dispos       Date:  2011-04-01       Impact factor: 3.922

3.  Heteroactivation of cytochrome P450 1A1 by teas and tea polyphenols.

Authors:  Dana L Anger; Maria-Alexandra Petre; Denis J Crankshaw
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

Review 4.  Development and Uses of Offline and Web-Searchable Metabolism Databases - The Case of Benzo[a]pyrene.

Authors:  Slobodan P Rendic; Frederick P Guengerich
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

5.  Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara.

Authors:  Denise C Endringer; Keller G Guimarães; Tamara P Kondratyuk; John M Pezzuto; Fernão C Braga
Journal:  J Nat Prod       Date:  2008-05-08       Impact factor: 4.050

Review 6.  Polyphenolic Nutrients in Cancer Chemoprevention and Metastasis: Role of the Epithelial-to-Mesenchymal (EMT) Pathway.

Authors:  Haneen Amawi; Charles R Ashby; Temesgen Samuel; Ramalingam Peraman; Amit K Tiwari
Journal:  Nutrients       Date:  2017-08-21       Impact factor: 5.717

7.  Taxifolin Inhibits 7,12-Dimethylbenz(a)anthracene-induced Breast Carcinogenesis by Regulating AhR/CYP1A1 Signaling Pathway.

Authors:  Md Wasimul Haque; Shakti Prasad Pattanayak
Journal:  Pharmacogn Mag       Date:  2018-01-31       Impact factor: 1.085

Review 8.  Role of Resveratrol in Regulating Cutaneous Functions.

Authors:  Si Wen; Jiechen Zhang; Bin Yang; Peter M Elias; Mao-Qiang Man
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-14       Impact factor: 2.629

9.  Interaction of Thalassia testudinum Metabolites with Cytochrome P450 Enzymes and Its Effects on Benzo(a)pyrene-Induced Mutagenicity.

Authors:  Livan Delgado-Roche; Rebeca Santes-Palacios; José A Herrera; Sandra L Hernández; Mario Riera; Miguel D Fernández; Fernando Mesta; Gabino Garrido; Idania Rodeiro; Jesús Javier Espinosa-Aguirre
Journal:  Mar Drugs       Date:  2020-11-19       Impact factor: 5.118

10.  Cytochrome P450 CYP1B1 activity in renal cell carcinoma.

Authors:  M C E McFadyen; W T Melvin; G I Murray
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.